The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Budesonide Teva Pharma 1 mg/2 ml Nebuliser Suspension

Teva Pharma B.V.PA0749/207/003

Main Information

Trade NameBudesonide Teva Pharma 1 mg/2 ml Nebuliser Suspension
Active SubstancesBudesonide
Dosage FormNebuliser suspension
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/207/003

Group Information

ATC CodeR03BA Glucocorticoids
R03BA02 budesonide


License statusAuthorised
Licence Issued07/03/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back